Cargando…

Crosstalk between TM4SF5 and GLUT8 regulates fructose metabolism in hepatic steatosis

OBJECTIVE: Transmembrane 4 L six family member 5 (TM4SF5) is likely involved in non-alcoholic steatohepatitis, although its roles and cross-talks with glucose/fructose transporters in phenotypes derived from high-carbohydrate diets remain unexplored. Here, we investigated the modulation of hepatic f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hyejin, Kim, Eunmi, Shin, Eun-Ae, Shon, Jong Cheol, Sun, Hyunseung, Kim, Ji Eon, Jung, Jae Woo, Lee, Haesong, Pinanga, Yangie, Song, Dae-Geun, Liu, Kwang-Hyeon, Lee, Jung Weon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866669/ https://www.ncbi.nlm.nih.gov/pubmed/35123128 http://dx.doi.org/10.1016/j.molmet.2022.101451

Ejemplares similares

Systemic TM4SF5 overexpression in Apc(Min/+) mice promotes hepatic portal hypertension associated with fibrosis
por: Lee, Joohyeong, et al.
Publicado: (2022)

TM4SF5-mediated abnormal food-intake behavior and apelin expression facilitate non-alcoholic fatty liver disease features
por: Pinanga, Yangie Dwi, et al.
Publicado: (2023)

Liver‐originated small extracellular vesicles with TM4SF5 target brown adipose tissue for homeostatic glucose clearance
por: Jung, Jae Woo, et al.
Publicado: (2022)

TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypes
por: Sun, Hyunseung, et al.
Publicado: (2021)

Amino acid transporters as tetraspanin TM4SF5 binding partners
por: Jung, Jae Woo, et al.
Publicado: (2020)

TM4SF5-Mediated Regulation of Hepatocyte Transporters during Metabolic Liver Diseases
por: Kim, Ji Eon, et al.
Publicado: (2022)

TM4SF5-mediated CD44v8-10 splicing variant promotes survival of type II alveolar epithelial cells during idiopathic pulmonary fibrosis
por: Kim, Ji Eon, et al.
Publicado: (2019)

N-terminus-independent activation of c-Src via binding to a tetraspan(in) TM4SF5 in hepatocellular carcinoma is abolished by the TM4SF5 C-terminal peptide application
por: Song, Haeng Eun, et al.
Publicado: (2021)

TM4SF5-mediated protein-protein networks and tumorigenic roles
por: Lee, Jung Weon
Publicado: (2014)

TM4SF5-Mediated Roles in the Development of Fibrotic Phenotypes
por: Ryu, Jihye, et al.
Publicado: (2017)

Anti-cancer Activity of Novel TM4SF5-Targeting Antibodies through TM4SF5 Neutralization and Immune Cell-Mediated Cytotoxicity
por: Ahn, Hye-Mi, et al.
Publicado: (2017)

Membrane Proteins Involved in Epithelial-Mesenchymal Transition and Tumor Invasion: Studies on TMPRSS4 and TM4SF5
por: Kim, Semi, et al.
Publicado: (2014)

Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer models
por: Ko, Dongjoon, et al.
Publicado: (2022)

TM4SF5 promotes metastatic behavior of cells in 3D extracellular matrix gels by reducing dependency on environmental cues
por: Song, Dae-Geun, et al.
Publicado: (2017)

Self-renewal and circulating capacities of metastatic hepatocarcinoma cells required for collaboration between TM4SF5 and CD44
por: Lee, Doohyung, et al.
Publicado: (2015)

TM4SF5 Knockout Protects Mice From Diet-Induced Obesity Partly by Regulating Autophagy in Adipose Tissue
por: Choi, Cheoljun, et al.
Publicado: (2021)

Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cells
por: Park, Sangkyu, et al.
Publicado: (2020)

Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance
por: Rahim, Nur Syafiqah, et al.
Publicado: (2023)

Structure and mechanism of the mammalian fructose transporter GLUT5
por: Nomura, Norimichi, et al.
Publicado: (2015)

Fructose fuels lung adenocarcinoma through GLUT5
por: Weng, Yuanyuan, et al.
Publicado: (2018)

GLUT5 increases fructose utilization in ovarian cancer
por: Jin, Cuiping, et al.
Publicado: (2019)

Down-regulation of TM4SF is associated with the metastatic potential of gastric carcinoma TM4SF members in gastric carcinoma
por: Chen, Zhouxun, et al.
Publicado: (2011)

Correlations between Transmembrane 4 L6 Family Member 5 (TM4SF5), CD151, and CD63 in Liver Fibrotic Phenotypes and Hepatic Migration and Invasive Capacities
por: Kang, Minkyung, et al.
Publicado: (2014)

MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1
por: Park, Young Ran, et al.
Publicado: (2018)

TM4SF4 and LRRK2 Are Potential Therapeutic Targets in Lung and Breast Cancers through Outlier Analysis
por: Jung, Kyungsoo, et al.
Publicado: (2021)

TM6SF2 rs58542926 is related to hepatic steatosis, fibrosis and serum lipids both in adults and children: A meta-analysis
por: Li, Xue-Ying, et al.
Publicado: (2022)

Determinants of sugar-induced influx in the mammalian fructose transporter GLUT5
por: McComas, Sarah E, et al.
Publicado: (2023)

The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis
por: Liu, Zhengtao, et al.
Publicado: (2017)

Myeloid TM6SF2 Deficiency Inhibits Atherosclerosis
por: Zhu, Wenzhen, et al.
Publicado: (2022)

Anti-metastatic effect of the TM4SF5-specific peptide vaccine and humanized monoclonal antibody on colon cancer in a mouse lung metastasis model
por: Wu, Guang, et al.
Publicado: (2016)

Variations in TM6SF2, PCSK9 and PCSK7 genes and risk of hepatic steatosis after liver transplantation: a cross-sectional study
por: Eshraghian, Ahad, et al.
Publicado: (2021)

Therapeutic effect of a TM4SF5-specific peptide vaccine against colon cancer in a mouse model
por: Kwon, Sanghoon, et al.
Publicado: (2014)

Surgical Outcomes of Congenital Atrial Septal Defect Using da VinciTM Surgical Robot System
por: Kim, Ji Eon, et al.
Publicado: (2013)

A peptide-CpG-DNA-liposome complex vaccine targeting TM4SF5 suppresses growth of pancreatic cancer in a mouse allograft model
por: Park, Sangkyu, et al.
Publicado: (2018)

SGLT5 Reabsorbs Fructose in the Kidney but Its Deficiency Paradoxically Exacerbates Hepatic Steatosis Induced by Fructose
por: Fukuzawa, Taku, et al.
Publicado: (2013)

Coding variants in PNPLA3 and TM6SF2 are risk factors for hepatic steatosis and elevated serum alanine aminotransferases caused by a glucagon receptor antagonist
por: Guzman, Cristina B., et al.
Publicado: (2018)

Therapeutic effect of a TM4SF5-specific monoclonal antibody against colon cancer in a mouse model
por: Kim, Young-Eun, et al.
Publicado: (2014)

TM4SF4 overexpression in radiation-resistant lung carcinoma cells activates IGF1R via elevation of IGF1
por: Choi, Soo-Im, et al.
Publicado: (2014)

Osteopontin production by TM4SF4 signaling drives a positive feedback autocrine loop with the STAT3 pathway to maintain cancer stem cell-like properties in lung cancer cells
por: Choi, Soo Im, et al.
Publicado: (2017)

Impact of liver-specific GLUT8 silencing on fructose-induced inflammation and omega oxidation
por: Novelle, Marta G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k5pkbhqg5kj9jdm0t8k14hvjan